Skip to main content
SpringerLink
Log in

Clozapine for the treatment-resistant schizophrenic: results of a US multicenter trial

  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Claghorn J, Honigfeld G, Abuzzahab FS, Wans R Steinbook R, Tuason V, Klerman G (1987) The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7:377–384

    Google Scholar 

  • Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–483

    Google Scholar 

  • Davis JM, Schaffer CB, Killian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6:70–87

    Google Scholar 

  • Fischer-Cornelssen KA, Ferner UJ (1976) An example of European multicenter trials: multispectral analysis of clozapine Psychopharmacol Bull 12:34–39

    Google Scholar 

  • Griffith RW, Saameli K (1975) Clozapine and agranulocytosis. Lancet II:657

    Google Scholar 

  • Kane IM, Cooper TB, Sachar EJ, Halpern FS, Bailine S (1981) Clozapine: plasma levels and prolactin response. Psychopharmacology 73:184–187

    Google Scholar 

  • Klein DF, Davis JM (1969) Diagnosis and drug treatment of psychiatric disorders. Willaims & Wilkins, Baltimore

    Google Scholar 

  • Meltzer HY, Goode DJ, Schyve PM, Young M, Fang VS (1979) Effect of clozapine on human serum prolactin levels. Am J Psychiatry 136:1550–1555

    Google Scholar 

  • Sackett DL, Gent M (1979) Controversy in counting and attributing events in clinical trials. N Engl J Med 301:1410–1412

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Hillside Hospital, Division of Long Island Jewish Medical Center, 11004, Glen Oaks, NY, USA

    John M. Kane

  2. Department of Psychiatry, Albert Einstein College of Medicine, Bronx, NY, USA

    John M. Kane

  3. Sandoz Research Institute, Route 10, P.O. Box 11, 07936, East Hanover, NJ, USA

    Gilbert Honigfeld, Jack Singer & Herbert Meltzer

  4. Department of Psychiatry, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, USA

    Jack Singer

  5. Department of Psychiatry, Case Western Reserve School of Medicine, 2040 Abington Road, 44106, Cleveland, OH, USA

    Herbert Meltzer

Authors
  1. John M. Kane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gilbert Honigfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jack Singer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Herbert Meltzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the Clozaril Collaborative Study Group

Additional information

These data were originally published in Arch Gen Psychiatry 1988; 45:789–796 and are reprinted with permission

Joyce Small, Richard Borison, Rob Conley, Richard Wagner, Jan Volavka, John Rotrosen, Donald Seidel, Larry Ereshefsky, Jerome Costa, John Herrera, Samuel Gershon, Neil Hartman, George Simpson, Richard Abrams, Benjamin Graber, and Martha Martin. Statistical analyses performed by John Patin

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kane, J.M., Honigfeld, G., Singer, J. et al. Clozapine for the treatment-resistant schizophrenic: results of a US multicenter trial. Psychopharmacology 99 (Suppl 1), S60–S63 (1989). https://doi.org/10.1007/BF00442561

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442561

Keywords

Search

Navigation